Abstract:Tripartite motif (TRIM) 59 protein, a cancer-associated E3 ubiquitin ligase, plays important roles in various biological processes including innate immune response, autophagy, cell cycle, glycolysis and tumorigenicity. The mechanism of autophagy regulated by TRIM59 in non-small cell lung cancer (NSCLC) has been elucidated clearly. It has been demonstrated that TRIM59 was a novel molecule prognostic factor of NSCLC and frequently up-regulated in NSCLC patients, that was verified in The Cancer Genome Atlas (TCGA) datasets. Nevertheless, it still remains unclear of the correlation between TRIM59 expression and immune infiltrates as well as the predictive value of TRIM59 in lung adenocarcinoma (LUAD). In this study, analysis of TRIM59 expression in normal and tumor tissues indicated that TRIM59 was up-regulated in most tumor tissues based on RNA-seq datasets from TCGA and Genotype-Tissue Expression (GTEx) databases. The correlation analysis between TRIM59 expression and overall survival (OS), disease-specifical survival (DSS), disease-free interval (DFI) or progress free interval (PFI), suggested that high TRIM59 expression predicted adverse outcomes in LUAD (OS: P=0.00096; DSS: P=0.00056; DFI: P=0.0009; PFI: P=0.0012). The correlation analysis between TRIM59 and immune checkpoints revealed that TRIM59 was significantly correlated with most of immune checkpoints in TCGA database, and TRIM59 had significant correlation with TMB (P<0001), ESITIMATE score (P=0.04) or stromal score (P=0.005) in LUAD. Further investigation demonstrated that the significantly negative correlation between TRIM59 expression and tumor purity was only shown in LUAD (P=0.027). It was found that TRIM59 had significant correlation with gene markers on macrophage and neutrophil in Tumor Immune Estimation Resource (TIMER) database, indicating that TRIM59 expression in LUAD played an essential regulatory role in tumor immune progress including infiltration of macrophage and neutrophil. Functional enrichment analysis as well as correlation analysis between TRIM59 and clinical characteristics of LUAD patients was also performed in our report. Combined with previously reported prognostic role of TRIM59 in NSCLC, our results proved that TRIM59 is a prognosticator for LUAD and is correlated with immune infiltrates in LUAD. Funding Statement: This work was supported by the National Natural Science Foundation of China (81703072), The Natural Science Foundation of Zhejiang Province (LQ21H160027). Declaration of Interests: The authors have no conflict of interests.

High Expression of Trim29 (atdc) Contributes to Poor Prognosis and Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Osteosarcoma

Trim14 Regulates Cell Proliferation and Invasion in Osteosarcoma Via Promotion of the Akt Signaling Pathway

TRIM29 Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Activating Wnt/β-catenin Pathway in Cervical Cancer.

Up-regulation of Tripartite Motif-Containing 29 Promotes Cancer Cell Proliferation and Predicts Poor Survival in Colorectal Cancer

TRIM29 is Differentially Expressed in Colorectal Cancers of Different Primary Locations and Affects Survival by Regulating Tumor Immunity Based on Retrospective Study and Bioinformatics Analysis

TRIM26 Inhibited Osteosarcoma Progression Through Destabilizing RACK1 and Thus Inactivation of MEK/ERK Signaling.

High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer

Integrated Bioinformatics Analysis Reveals Correlations of High TRIM59 Expression with Worse Prognosis and Immune Infiltrates in Lung Adenocarcinoma

High TRIM59 Expression Predicts Adverse Outcomes and is Correlated with Immune Infiltrates in Lung Adenocarcinoma

Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma.

Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma

TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond

N6-Methyladenosine Modification of the TRIM7 Positively Regulates Tumorigenesis and Chemoresistance in Osteosarcoma Through Ubiquitination of BRMS1

TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750

Abstract 3902: TRIM33 interacts with HSF1 in osteosarcoma development

TRIM29 Promotes Progression of Thyroid Carcinoma Via Activating P13K/AKT Signaling Pathway.

Minichromosome Maintenance Protein 2 and 3 Promote Osteosarcoma Progression Via Dhx9 and Predict Poor Patient Prognosis

TRIM59: A potential diagnostic and prognostic biomarker in human tumors

TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma

TRIM28 as an independent prognostic marker plays critical roles in glioma progression

MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma